Mpm Bioventures V, L.p. - Net Worth and Insider Trading
Mpm Bioventures V, L.p. Net Worth
The estimated net worth of Mpm Bioventures V, L.p. is at least $303 Million dollars as of 2024-09-20. Mpm Bioventures V, L.p. is the 10% Owner of Rhythm Pharmaceuticals Inc and owns about 5,292,784 shares of Rhythm Pharmaceuticals Inc (RYTM) stock worth over $289 Million. Mpm Bioventures V, L.p. is also the 10% Owner of Aratana Therapeutics Inc and owns about 2,867,255 shares of Aratana Therapeutics Inc (PETX) stock worth over $14 Million. Details can be seen in Mpm Bioventures V, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mpm Bioventures V, L.p. has not made any transactions after 2017-10-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mpm Bioventures V, L.p.
Mpm Bioventures V, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mpm Bioventures V, L.p. owns 5 companies in total, including Rhythm Pharmaceuticals Inc (RYTM) , Avalo Therapeutics Inc (AVTX) , and Aratana Therapeutics Inc (PETX) among others .
Click here to see the complete history of Mpm Bioventures V, L.p.’s form 4 insider trades.
Insider Ownership Summary of Mpm Bioventures V, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RYTM | Rhythm Pharmaceuticals Inc | 2017-10-10 | 10 percent owner |
| AVTX | Avalo Therapeutics Inc | 2015-10-14 | 10 percent owner |
| PETX | Aratana Therapeutics Inc | 2014-03-10 | 10 percent owner |
 | | 2013-07-24 | 10 percent owner |
| | 2012-01-26 | other: Former 10% stockholder |
Mpm Bioventures V, L.p. Latest Holdings Summary
Mpm Bioventures V, L.p. currently owns a total of 2 stocks. Among these stocks, Mpm Bioventures V, L.p. owns 5,292,784 shares of Rhythm Pharmaceuticals Inc (RYTM) as of October 10, 2017, with a value of $289 Million and a weighting of 95.35%. Mpm Bioventures V, L.p. also owns 2,867,255 shares of Aratana Therapeutics Inc (PETX) as of March 10, 2014, with a value of $14 Million and a weighting of 4.65%.
Latest Holdings of Mpm Bioventures V, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RYTM | Rhythm Pharmaceuticals Inc | 2017-10-10 | 5,292,784 | 54.63 | 289,144,790 |
| PETX | Aratana Therapeutics Inc | 2014-03-10 | 2,867,255 | 4.92 | 14,106,895 |
Holding Weightings of Mpm Bioventures V, L.p.
Mpm Bioventures V, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Mpm Bioventures V, L.p. has made a total of 0 transactions in Rhythm Pharmaceuticals Inc (RYTM) over the past 5 years. The most-recent trade in Rhythm Pharmaceuticals Inc is the acquisition of 100,000 shares on October 10, 2017, which cost Mpm Bioventures V, L.p. around $2 Million.
According to the SEC Form 4 filings, Mpm Bioventures V, L.p. has made a total of 0 transactions in Aratana Therapeutics Inc (PETX) over the past 5 years. The most-recent trade in Aratana Therapeutics Inc is the sale of 600,000 shares on March 10, 2014, which brought Mpm Bioventures V, L.p. around $12 Million.
Insider Trading History of Mpm Bioventures V, L.p.
- 1
Mpm Bioventures V, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Mpm Bioventures V, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mpm Bioventures V, L.p. is 66.38%. GuruFocus also compares Mpm Bioventures V, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Mpm Bioventures V, L.p. within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mpm Bioventures V, L.p.'s insider trading performs compared to the benchmark.
Performance of Mpm Bioventures V, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.21 | | | | | |
| Relative Return to S&P 500(%) | 3.63 | | | | | |
Mpm Bioventures V, L.p. Ownership Network
Mpm Bioventures V, L.p. Owned Company Details
What does Rhythm Pharmaceuticals Inc do?
Who are the key executives at Rhythm Pharmaceuticals Inc?
Mpm Bioventures V, L.p. is the 10 percent owner of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Chief Human Resources Officer Pamela J. Cramer , Chief Technical Officer Joseph Shulman , and Corporate Controller & CAO Christopher Paul German .
Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary
Over the past 18 months, Mpm Bioventures V, L.p. made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 171,662 shares made by Joseph Shulman , a net sale of 78,894 shares made by Jennifer Chien , and a net sale of 75,787 shares made by Pamela J. Cramer .
In summary, during the past 3 months, insiders sold 191,981 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 191,981 shares. During the past 18 months, 583,578 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 583,578 shares.
Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rhythm Pharmaceuticals Inc Insider Transactions
Mpm Bioventures V, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Mpm Bioventures V, L.p.. You might contact Mpm Bioventures V, L.p. via mailing address: Mpm Asset Management, 200 Clarendon Street, 54th Floor, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
